Back to search

Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation

Data up to Jan 2025

Published2002
Citations330
References85

Total Citations Per Year

Abstract

References (85)

Wnt signaling and cancer

2000 • 3,215 citations

A molecular mechanism for the effect of lithium on development.

1996 • 2,270 citations

Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen

2001 • 1,684 citations

The renaissance of GSK3

2001 • 1,459 citations

The multifaceted roles of glycogen synthase kinase 3β in cellular signaling

2001 • 1,408 citations

Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation

2000 • 1,365 citations

Molecular cloning and expression of glycogen synthase kinase-3/factor A.

1990 • 1,329 citations

Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cells

1996 • 1,299 citations

GSK3 takes centre stage more than 20 years after its discovery

2001 • 1,298 citations

Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta -catenin and promotes GSK-3beta -dependent phosphorylation of beta -catenin

1998 • 1,244 citations

GSK3 takes centre stage more than 20 years after its discovery

2001 • 939 citations

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription

2000 • 867 citations

Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases

1999 • 784 citations

Indirubins Inhibit Glycogen Synthase Kinase-3β and CDK5/P25, Two Protein Kinases Involved in Abnormal Tau Phosphorylation in Alzheimer's Disease

2001 • 685 citations

A Common Phosphate Binding Site Explains the Unique Substrate Specificity of GSK3 and Its Inactivation by Phosphorylation

2001 • 679 citations

Crystal Structure of Glycogen Synthase Kinase 3β

2001 • 636 citations

The role of protein phosphorylation in human health and disease.

2001 • 596 citations

The NF-κB Activation Pathway: A Paradigm in Information Transfer from Membrane to Nucleus

1999 • 485 citations

Lithium Inhibits Glycogen Synthase Kinase-3 by Competition for Magnesium

2001 • 482 citations

Lithium Reduces Tau Phosphorylation by Inhibition of Glycogen Synthase Kinase-3

1997 • 459 citations

Chinese Drugs of Plant Origin: Chemistry, Pharmacology, and Use in Traditional and Modern Medicine

1992 • 454 citations

The Mood‐Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase‐3

2000 • 434 citations

First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease

2002 • 430 citations

Inhibition of cyclin-dependent kinases, GSK-3β and CK1 by hymenialdisine, a marine sponge constituent

2000 • 419 citations

Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B

1993 • 399 citations

Glucose Sensing in Pancreatic β-Cells

2001 • 396 citations

Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy

2000 • 390 citations

Structure of GSK3beta reveals a primed phosphorylation mechanism.

2001 • 368 citations

Cyclic AMP Promotes Neuronal Survival by Phosphorylation of Glycogen Synthase Kinase 3β

2000 • 361 citations

Paullones are potent inhibitors of glycogen synthase kinase‐3β and cyclin‐dependent kinase 5/p25

2000 • 361 citations

Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death

2001 • 361 citations

Spatial learning deficit in transgenic mice that conditionally over‐express GSK‐3β in the brain but do not form tau filaments

2002 • 360 citations

Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.

2000 • 344 citations

The Molecular Bases of Alzheimer's Disease and Other Neurodegenerative Disorders

2001 • 337 citations

Lithium inhibits Alzheimer's disease‐like tau protein phosphorylation in neurons

1997 • 315 citations

Paullones, a Series of Cyclin-Dependent Kinase Inhibitors: Synthesis, Evaluation of CDK1/Cyclin B Inhibition, and in Vitro Antitumor Activity

1999 • 314 citations

Judging a Protein by More Than Its Name: GSK-3

2001 • 281 citations

Lithium protects cultured neurons against β‐amyloid‐induced neurodegeneration

1999 • 269 citations

Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases.

1999 • 219 citations

GSK3, a master switch regulating cell-fate specification and tumorigenesis

2000 • 219 citations

Inhibition of GSK-3 Selectively Reduces Glucose-6-Phosphatase and Phosphoenolpyruvate Carboxykinase Gene Expression

2001 • 215 citations

The Structure of Phosphorylated GSK-3β Complexed with a Peptide, FRATtide, that Inhibits β-Catenin Phosphorylation

2001 • 194 citations

Phosphorylation of human tau protein by microtubule-associated kinases: GSK3? and cdk5 are key participants

2000 • 173 citations

Current Therapies and Emerging Targets for the Treatment of Diabetes

2001 • 167 citations

3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3)

2001 • 156 citations

Lithium therapy and signal transduction

2000 • 155 citations

Lithium reduces tau phosphorylation: effects in living cells and in neurons at therapeutic concentrations

1999 • 154 citations

Glycogen Synthase Kinase 3β Negatively Regulates Both DNA-binding and Transcriptional Activities of Heat Shock Factor 1

2000 • 154 citations

Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilisers

2001 • 141 citations

The protein kinase C inhibitors bisindolylmaleimide I (GF 109203x) and IX (Ro 31‐8220) are potent inhibitors of glycogen synthase kinase‐3 activity

1999 • 140 citations

Anti-mitotic properties of indirubin-3′-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest

2001 • 134 citations

A Structure-Based Library Approach to Kinase Inhibitors

1996 • 125 citations

Neurofibrillary tangles and tau phosphorylation

2001 • 123 citations

Low GSK-3 activity in frontal cortex of schizophrenic patients

2001 • 123 citations

Dishevelled Regulates the Metabolism of Amyloid Precursor Protein via Protein Kinase C/Mitogen-Activated Protein Kinase and c-Jun Terminal Kinase

2001 • 119 citations

Identification of the Axin and Frat Binding Region of Glycogen Synthase Kinase-3

2002 • 113 citations

Expression analysis of glycogen synthase kinase‐3 in human tissues

1999 • 112 citations

Lithium inhibits caspase 3 activation and dephosphorylation of PKB and GSK3 induced by K+deprivation in cerebellar granule cells

2001 • 99 citations

Integrin-linked kinase (ILK): a “hot” therapeutic target

2000 • 98 citations

Glycogen Synthase Kinase-3β Regulates Presenilin 1 C-terminal Fragment Levels

2001 • 98 citations

GSK‐3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and β‐catenin stabilisation without elevation of glycogen synthase activity

2001 • 87 citations

Selective small‐molecule inhibitors of glycogen synthase kinase‐3 activity protect primary neurones from death

2001 • 84 citations

Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3β inhibition and in neurons

2000 • 83 citations

N-Benzylpiperidine derivatives of 1,2,4-thiadiazolidinone as new acetylcholinesterase inhibitors

2000 • 77 citations

Therapeutic Strategies in Alzheimer’s Disease: Ml Muscarinic Agonists

2000 • 74 citations

Molecular Cloning and Characterization of the Human Glycogen Synthase Kinase-3β Promoter

1999 • 68 citations

M1 Muscarinic Agonists as Potential Disease‐Modifying Agents in Alzheimer's Disease: Rationale and Perspectives

2000 • 62 citations

Phosphorylation of tau by glycogen synthase kinase 3β in intact mammalian cells influences the stability of microtubules

2001 • 60 citations

Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 β gene and promoter in late onset Alzheimer's disease

2001 • 60 citations

Missing Links in GSK3 Regulation

2001 • 59 citations

The natural product hymenialdisine inhibits interleukin-8 production in U937 cells by inhibition of nuclear factor-kappaB.

1997 • 57 citations

Lithium-related genetics of bipolar disorder

2001 • 46 citations

Non-Cholinergic Pharmacotherapy Approaches to the Future Treatment of Alzheimers Disease

2002 • 40 citations

Inhibition of tau phosphorylation: a new therapeutic strategy for the treatment of Alzheimer’s disease and other neurodegenerative disorders

2000 • 39 citations

Synthesis and Potential Muscarinic Receptor Binding and Antioxidant Properties of 3-(Thiadiazolyl)pyridine 1-Oxide Compounds

1999 • 38 citations

Inhibition of voltage‐dependent sodium channels by Ro 31‐8220, a ‘specific’ protein kinase C inhibitor

2000 • 34 citations

Glycogen synthase kinase 3 phosphorylation of different residues in the presence of different factors: Analysis on tau protein

1996 • 33 citations

Different expression of glycogen synthase kinase-3βbetween young and old rat brains after transient middle cerebral artery occlusion

2001 • 33 citations

Synthese von 7,12‐Dihydro‐indolo[3,2‐d][1]benzazepin‐6‐(5H)‐onen und 6,11‐Dihydro‐thieno‐[3′,2′:2,3]azepino[4,5‐b]indol‐5(4H)‐on

1992 • 32 citations

The interaction between β-catenin, GSK3β and APC after motogen induced cell-cell dissociation, and their involvement in signal transduction pathways in prostate cancer

2001 • 23 citations

Reactions of N‐Alkyl‐ and N‐Aryl‐S‐chloroisothiocarbamoyl Chlorides with Isocyanates; Synthesis of 1,2,4‐Thiadiazolidine‐3,5‐diones

1966 • 16 citations

Arylimino-1,2,4-thiadiazolidinones: A new family of potassium channel openers

1997 • 16 citations

Experimentally Induced Benignancy of Neoplasm. V. The Influence of Hormones on the Host's Resistance to Implanted Neoplasm

1941 • 10 citations

Traditional and Modern Medicine

2016 • 6 citations

Glycogen synthase kinase-3beta as a target for anti-apoptotic signals

2001 • 1 citations

Cited By (0)

Loading...
Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes,… (2002) – Medicinal Research Reviews | Metascience Observatory Explorer